So if you're on Ozempic, Zepbound KwikPen, a compounded GLP-1 device that uses pen needles, or any traditional insulin pen, keep reading
Philadelphia: The Pew Charitable Trusts
Accessed 01/08/2026 at Wharton, S., Freitas, P., Hjelmesth, J., Kabisch, M., Kandler, K., Lingvay, I., Quiroga, M., Rosenstock, J., Garvey, W
Please contact our Wellness Team for more information
In the Phase 2 obesity trial published in the New England Journal of Medicine, the highest arm reached 24.2 percent average body weight loss at 48 weeks, and the curve had not flattened by the end
Combining prescription weight management treatments with unregulated supplements raises important safety considerations